Rationing Medications: How Ethical Decisions Are Made During Drug Shortages

  • Home
  • Rationing Medications: How Ethical Decisions Are Made During Drug Shortages
Rationing Medications: How Ethical Decisions Are Made During Drug Shortages

When a life-saving drug runs out, who gets it? This isn’t science fiction. In 2023, hospitals across the U.S. faced severe shortages of carboplatin and cisplatin-two key chemotherapy drugs used to treat ovarian, lung, and testicular cancers. Some patients waited weeks for treatment. Others were told their dose would be cut in half. A few didn’t get it at all. Behind these decisions were teams of doctors, pharmacists, and ethicists trying to do the right thing under impossible conditions.

Why Medication Rationing Happens

Drug shortages aren’t new, but they’ve gotten worse. In 2005, there were 61 reported shortages in the U.S. By 2023, that number jumped to 319. The biggest culprits? Generic injectable drugs-especially cancer meds, antibiotics, and anesthetics. Three companies control 80% of the supply for these critical drugs. If one factory shuts down for quality issues, or if a raw material gets delayed overseas, the whole system stumbles.

The FDA requires manufacturers to give a six-month heads-up before a shortage hits. But only 68% actually do. That leaves hospitals scrambling. In community clinics, 87% reported severe shortages of key chemo drugs. Even big hospitals weren’t safe-63% struggled to keep up.

When supply drops below demand, doctors can’t just prescribe what’s needed. They have to choose. And that’s where ethics kicks in.

What Ethical Rationing Actually Looks Like

Ethical rationing isn’t about picking patients based on age, income, or who screams loudest. It’s about using clear, fair rules so no one’s left to guess who gets treated.

The most trusted framework comes from ethicists Daniel and Sabin. Their model has four rules:

  • Publicity: Everyone knows how decisions are made.
  • Relevance: Decisions are based on medical facts-not gut feelings.
  • Appeals: Patients or families can challenge a decision.
  • Enforcement: Someone checks that the rules are followed.
In oncology, ASCO (the American Society of Clinical Oncology) added more detail. They say rationing should happen at the hospital level-not at the bedside. That means a committee, not one tired oncologist making a call at 2 a.m. The committee should include pharmacists, nurses, doctors, social workers, patient advocates, and yes-even ethicists.

They also say: prioritize patients who have the best chance of survival, especially if there’s no other drug that works. For example, a stage III cancer patient with curative intent gets priority over someone with advanced disease where chemo is only for comfort.

What Happens When There’s No System

Too often, there’s no committee. No rules. Just whoever’s on call deciding who gets the last vial.

A 2022 study found 52% of rationing decisions were made by individual clinicians-no review, no discussion. That leads to chaos. One nurse in Texas told a reporter she had to give her last dose to a 28-year-old because the 68-year-old “had already had a good life.” That’s not ethics. That’s grief talking.

Bedside rationing also burns out staff. Clinicians who make these calls alone are 27% more likely to report burnout. And patients? Only 36% are told they’re being rationed. Imagine being told your treatment is delayed-without knowing why. That’s not just unfair. It’s traumatic.

Hospitals with formal committees report 41% less moral distress among staff. They also see fewer disparities. Patients of color, low-income patients, and those without strong advocates are far more likely to be left out when decisions are made informally.

Oncologist holding half-dose chemo syringe, staring at patient chart in dim clinic

How Hospitals Are Trying to Fix This

Some places are getting better. Minnesota’s Department of Health released a detailed guide in April 2023 for carboplatin and cisplatin shortages. It didn’t just say “be fair.” It said:

  • Tier 1: Curative intent, no alternative drug available
  • Tier 2: Palliative intent, but high chance of symptom control
  • Tier 3: Low benefit, high risk
They also pushed for dose optimization-using the lowest effective dose over a longer time. That stretched supplies by 20-30% in some hospitals.

Other hospitals started tracking every dose. They built digital logs in their electronic records that ask: Why was this patient prioritized? Was the family told? Was an alternative offered? Only 22% of hospitals do this right now.

The CDC and ASCO now offer free tools to help. ASCO’s online decision support tool, launched in May 2023, walks teams through a step-by-step checklist. It’s not perfect-but it’s a start.

The Big Gaps

Even with good frameworks, big problems remain.

Rural hospitals? 68% have no formal rationing plan. They don’t have ethicists on staff. No pharmacy teams. Sometimes, they don’t even have a pharmacist on-site.

And equity? Most protocols don’t even measure it. A 2021 report found 78% of rationing guidelines ignore race, income, or language barriers. That means patients who already face healthcare gaps get pushed further behind.

Doctors also say they’re not trained for this. In a 2023 survey, 89% of pharmacists said the biggest problem was inconsistent rules across departments. One unit hoards drugs. Another gives them away too fast. No one’s watching.

Three diverse hands reaching for a floating chemo vial with ethical principles glowing above

What’s Next?

The FDA is building an AI-powered early warning system to predict shortages before they happen. It’s supposed to cut shortage duration by 30% by 2025. That’s promising.

The National Academy of Medicine is working on national standards for ethical allocation. Draft criteria are due in early 2024. They’ll likely include metrics for fairness, survival benefit, and equity.

And in January 2024, pilot programs launched in 15 states to certify hospital rationing committees. Think of it like CPR certification-but for ethical drug allocation. Hospitals that pass get a seal of approval.

What You Can Do

If you or someone you love is facing a shortage:

  • Ask: Is there a formal committee making these decisions?
  • Ask: Can I see the criteria used to prioritize patients?
  • Ask: Was I told why my treatment changed?
  • Ask: Are there alternatives? Clinical trials?
Don’t be afraid to push. You have a right to know how decisions are made. If your hospital can’t answer, contact your state health department or a patient advocacy group. You’re not alone.

Final Thought

Rationing isn’t about who deserves to live. It’s about who gets treated when there’s not enough to go around. And if we don’t make the rules clear, fair, and public-we’re not just failing patients. We’re failing the people who care for them.

Every doctor wants to help. But when they’re forced to play god without a manual, everyone loses. The solution isn’t more drugs-though we need those too. It’s better systems. Clear rules. And the courage to talk about hard choices before it’s too late.

Is medication rationing legal?

Yes, but only when done ethically and transparently. In the U.S., there’s no federal law mandating rationing, but courts have upheld hospital policies that follow clear, evidence-based guidelines. Rationing becomes illegal if it’s based on discrimination, bias, or secrecy. The key is having documented criteria, a review process, and patient notification.

Can I request a specific drug if it’s on shortage?

You can ask, but you can’t demand it. Hospitals must follow their allocation protocols. If you’re denied a drug, ask for the written policy, the reason for denial, and whether an appeal is possible. Some hospitals have patient advocates who can help navigate this process.

Why aren’t more hospitals using ethics committees?

Cost, time, and resistance. Setting up a committee takes training, staff time, and ongoing meetings. Many hospitals don’t have enough ethicists or pharmacists to staff them. Some doctors resist because they fear losing control over patient care. But data shows hospitals with committees have less burnout and fewer lawsuits.

Are there alternatives when a drug is unavailable?

Yes, but not always. For some cancer drugs like cisplatin, there are no equally effective substitutes. In those cases, doctors may use carboplatin instead, though it’s less effective for some tumors. For antibiotics, alternatives exist but may have more side effects. Always ask your care team: Is there another option? What are the trade-offs?

How can I find out if a drug I take is in short supply?

Check the FDA’s Drug Shortages page, which is updated weekly. Your pharmacist can also alert you. For cancer drugs, ASCO’s website has real-time alerts. If your medication is listed, talk to your doctor early-don’t wait until your refill runs out.

Back To Top